Topiramate
Topiramate is a prescription medication available as oral capsules in 15mg, 25mg, and 50mg strengths, manufactured by Advagen Pharma Ltd. It works by reducing disorganized electrical activity in the central nervous system and interacts with certain liver enzymes. Commonly used to treat seizures and prevent migraines. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Topiramate is a prescription medication available as oral capsules in 15mg, 25mg, and 50mg strengths, manufactured by Advagen Pharma Ltd. It works by reducing disorganized electrical activity in the central nervous system and interacts with certain liver enzymes. Commonly used to treat seizures and prevent migraines. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Topiramate",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Topiramate — ANDA 077627 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077627"
}
]
|
| identifier | ANDA077627 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-manufacturers",
"fda",
"pharmaceuticals",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Topiramate |
